Clinical Trials Browser

Phase 1 × Withdrawn × Aromatase Inhibitors × Clear all

NCT03846583 2020-10-23

Tucatinib + Abemaciclib + Herceptin for HER2+ MBC

Phase 1 Withdrawn

Breast Neoplasms

NCT00945360 2012-07-13

Aromatase Inhibitors for Treatment of Uterine Leiomyomas

Phase 1 Withdrawn

Leiomyoma